AstraZeneca deniers “missed the opportunity”: Berlin’s ruling mayor wants to change vaccine line – Berlin

Berlin’s ruling mayor, Michael Mல்லller (SPD), has spoken out in favor of adjusting the vaccine line. “At the same time, if millions of people across the country were to be immediately vaccinated with them, I would not allow tens of thousands of vaccine doses to be stored in our closet,” Mல்லller told Takespeek. Nationwide, only about 107,000 of the 740,000 AstraZeneca cans provided were vaccinated, with only a handful in Berlin wanting to be vaccinated.

“I will be vaccinated with Astrogeneneka immediately,” M முller said. “The vaccine provides the best protection against serious diseases.”

So far, the vaccine has been given to groups with their own method as per the recommendations of the Standard Vaccine Authority. “But if you do not want the vaccine, you have missed your chance. We will pass the vaccine on to others,” M முller said.

For this purpose, the ruling mayor wants to agree with other federal states on a practice as soon as possible. Next we need to explore which groups can be vaccinated with AstraZeneca. Mல்லller primarily recommends offers for teachers, educators, police and fire services, but vaccinations for retailers and staff on local transportation are also imaginable. “These professional groups have hundreds of contacts every day,” M முller said.

[Wenn Sie alle aktuellen Nachrichten live auf Ihr Handy haben wollen, empfehlen wir Ihnen unsere App, die Sie hier für Apple- und Android-Geräte herunterladen können.]

In Berlin, people under the age of 65 have so far been able to actually choose a vaccine. At the vaccination center in Tegel, thousands of astrogenogen levels were not vaccinated. So Health Senator Tilek Kalaisi (SPD) on Wednesday declared freedom of choice “probably wrong”.

A total of five million cans of the AstraZeneca brand are due to be delivered to Germany by April. Efficiency up to 70%, Biotech / Pfizer and Moderna up to 95%. However, an efficiency of 70 percent does not mean that the vaccine will not work in 30 out of 100 people who are vaccinated. Experts estimate that the performance is as good as the other two vaccines.